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Abstract: 
Embryo implantation is a complex interaction between maternal endometrium and 
embryonic structures. Failure in implantation is highly recurrent and impossible to 
diagnose. Inflammation and infections in the female reproductive tract are common 
causes of infertility, embryo loss and preterm-labor. The current work describes how the 
activation of endometrial Toll-like receptor (TLR) 2 and 2/6 reduces embryo 
implantation chances. We developed a morphometric index to evaluate the effects of the 
TLR 2/6 activation along the uterine horn (UH). TLR 2/6 ligation reduced the 
endometrial myometrial and glandular indexes and increased the luminal index. 
Furthermore, TLR 2/6 activation increased the pro-inflammatory cytokines such as 
Interleukin (IL)-ȕ and Monocyte Chemotactic Protein (MCP)-1 in UH lavages in the 
pre-implantation day and IL-1 Receptor Antagonist in the implantation day. The 
engagement of TLR 2/6 with its ligand in the uterine horn during embryo transfer 
severely affected the rate of embryonic implantation (45.00 ± 6.49 vs 16.69 ± 5.01%, p < 
0.05, control vs test; respectively). Furthermore, this interference with the embryo 
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implantation process was verified using an in vitro model of human embryo implantation 
where trophoblast spheroids failed to adhere to a monolayer of TLR 2 and TLR 2/6 
activated endometrial cells. The inhibition of TLR receptors 2 and 6 in the presence of 
their specific ligands, restored the ability of the spheroids to bind to the endometrial cells. 
In conclusion, the activation of the innate immune system in the uterus at the time of 
implantation interfered with the endometrial receptivity and reduced the chances of 
implantation success.  
 
Introduction 1 
Embryonic implantation is a critical event leading to a successful pregnancy[1]. The 2 
implantation process requires a complex orchestration of cellular and molecular events 3 
that include: expression of adhesion molecules, remodeling of the uterine extracellular 4 
matrix and an intricate crosstalk of hormones, cytokines and growth factors between the 5 
embryo and the endometrium[2-6]. Immune system plays an important role in the 6 
modulation of the mechanisms involved in implantation. Pregnancy represents an 7 
immunological contradiction in which a semi-allogeneic foreign entity, the embryo, is not 8 
rejected by the maternal immune system but accepted and nourished. This is achieved by 9 
several mechanisms, including the modulation of the maternal immune system by the pre-10 
implantation embryo[7]. Consequently, any interference that may imbalance the immune 11 
system responses could result in embryo loss and infertility. In fact, many infertility 12 
problems in women are associated with infections of the upper female reproductive tract 13 
(FRT) compartments: endocervix, fallopian tubes and uterus. The pathogens responsible 14 
for sexually transmitted diseases (STD) such as Mycoplasma genitalium, Neisseria 15 
gonorrhoeae and Chlamydia trachomatis have been associated with infertility in 16 
women[1,8]. 17 
The FRT is able to respond against these pathogenic entities and initiate an immune 18 
response. The first recognition of pathogens in the FRT is mediated by the innate immune 19 
system of epithelial, resident dendritic and natural killer (NK) cells[3,7,9]. This innate 20 
response will later prime and instruct the adaptive immune system to initiate cellular and 21 
humoral responses against pathogens[7,9,10]. In order to detect the potential pathogens, 22 
endometrial epithelial cells express pattern recognition receptors (PRRs) to common 23 
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pathogen-associated molecular patterns (PAMPs). One of the main families of PRRs is 24 
TLR family[9,11]. They can recognize a great variety of PAMPs from bacterial, fungal, 25 
parasitical and viral origin. The TLR family is formed by 10 members where each 26 
respond to a specific ligand that promotes the secretion of a different subset of cytokines 27 
and chemokines[12-15]. TLR 2 and its heterodimers with TLR 1 and TLR 6 can sense a 28 
great variety of PAMPs from pathogens that might be present in the FRT and can be 29 
activated by peptidoglycans (PGN) from bacteria (C. trachomatis, Staphylococcus 30 
aureus, N. gonorrhoeae, M. genitalium lipoproteins)[16], yeast (Candida albicans 31 
phospholipomannan)[17] and parasites (Trichomonas vaginalis lipophosphoglycan)[18].  32 
The heterodimer of TLR 2 and TLR 6 has been found to recognize the macrophage 33 
activated lipoprotein derived from Mycoplasma fermentans (MALP-2)[19]. FSL-1 is a 34 
specific and potent ligand for the heterodimer TLR 2/6 and was synthesized based on 35 
MALP-2 structure by changing its amino acid sequence[20]. Upon this recognition, they 36 
initiate signaling pathways that end up in the activation of the transcription factors 37 
nuclear factor (NF)-ț% RU $3-1 that promote the activation of pro-inflammatory 38 
genes[21]. 39 
 40 
The expression of TLRs 1-10 has been observed in mammalian uterus and in different 41 
human endometrial epithelial cell lines[13]. This expression follows the menstrual 42 
hormonal cycle. The highest level of TLR expression in the human endometrium has 43 
been observed during the late secretory phase, where implantation of the embryo takes 44 
place[22]. Although TLRs have been observed to be involved in a number of pregnancy 45 
disorders such as preterm labor, early pregnancy loss and pre-eclampsia[23], not much is 46 
 6 
known about their function during embryo implantation. Recent results from our 47 
laboratory have shown that activation of TLR5 by its ligand flagellin can interfere with 48 
trophoblast spheroids adhesion to epithelial cells in vitro[24].  49 
The study of the human embryo implantation process in vivo is limited due to the 50 
anatomical and the physiological restrictions and the ethical and the legal issues 51 
surrounding experimentation with human embryos. For these reasons, research on the 52 
embryo implantation has opted to employ different animal model species. The human 53 
embryo implantation is an invasive process, which makes it different from other 54 
mammalian species. The closest in vivo model to human is the primate embryo 55 
implantation[25] but the manipulation of these species is also limited due to ethical 56 
responsibility. The murine model is a good animal model that shares similar implantation 57 
characteristics with human embryo implantation such as its invasiveness[26]. It also 58 
offers many advantages like the possibility to manipulate their gametes and estrous cycle 59 
(between 4 to 5 days) and a short gestation (Approx. 3 weeks)[27]. Implantation of the 60 
murine embryo will take place on metestrus (day 4.5) the equivalent of the late secretory 61 
phase in human. Another alternative for the study of embryo implantation are the in vitro 62 
models where different cell lines, primary cells or tissue explants mimic both 63 
endometrium and embryo[28]. The selection of the appropriate cell lines is a fundamental 64 
issue to be considered due to the differences in endometrial and trophoblast cell 65 
developmental stages[28]. In the current investigation, we employed an in vitro model of 66 
human implantation, where the endometrium was simulated using the RL95-2 cell line 67 
which has been reported to maintain the epithelial polarization, express adhesion 68 
molecules and microfilaments in the apical surface and being responsive to hormones and 69 
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secretion of cytokines[29]. The breast carcinoma epithelial cells MCF7 were also 70 
employed in our investigations to observe if the trophoblasts were able to interact with 71 
another epithelial cell line. MCF7 maintain epithelial cell characteristics and are 72 
responsive to hormonal stimulation, hence they were used as another hormone responsive 73 
reproductive tissue from a non-endometrial origin[30]. The human embryo was simulated 74 
with multi-cellular spheroids from choriocarcinoma trophoblast cell line JAr. This cell 75 
line has been employed in different studies for its ability to establish adhesive interactions 76 
with endometrial cell lines in short periods of co-incubation[31]. 77 
 78 
In the current investigation, we determined if the activation of the TLR 2 could influence 79 
the implantation of the embryo. The problem was explored using two different 80 
approaches. Initially we used an in vivo murine embryo implantation model, to assess if 81 
the activation of TLR 2/6 in the UH may affect uterine morphology and secretory profile 82 
during implantation period as well as embryonic implantation. Thereafter, we 83 
corroborated these observations in an in vitro human implantation model. In summary, 84 
the activation of TLR 2/6 in vivo decreased the murine embryo implantation rate with 85 
significant changes in tissue morphology and protein secretion. In addition, the in vitro 86 
adhesion of trophoblast spheroids to the endometrial cells was affected specifically by the 87 
activation of the endometrial TLRs. 88 
 89 
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Materials and Methods 90 
Embryo transfer experiments 91 
Mice superovulation and mating 92 
C57/CBA mice were obtained from Harlan Laboratories. All mice used in the 93 
experiments were housed under controlled temperature conditions of 22°C with a 14/10 h 94 
light/dark cycle, 40-60% relative humidity and free access to water and food. Females 95 
were kept in cages of 1000 cm2 in groups of 8-10. Males were kept individually in 250 96 
cm2 cages. All animal experiments were performed in accordance with Institutional 97 
Animal Care and Use Committee guidelines from the INIA (Instituto Nacional de 98 
Investigación y Tecnología Agraria y Alimentaria) and in adherence with guidelines 99 
established in the Guide for Care and Use of Laboratory Animals as adopted and 100 
promulgated by the Society for the Study of Reproduction. Females were injected i.p. 101 
with 7.5 IU of equine chorionic gonadotropin (eCG; Foligon 500, Intervet), followed 48 h 102 
later by 7.5 IU of human chorionic gonadotropin (hCG; Veterin Corion, Equinvest). 103 
Thereafter each female was placed in a male cage (2:1) for mating. On the next day (day 104 
0.5 8:00-10:00 h) the females with vaginal plug were separated from the males. The 105 
selected mice were euthanized by cervical dislocation 3.5 days post-mating (embryos 106 
reached blastocyst stage). Both uterine horns were dissected and placed in a petri dish in 107 
pre-warmed M2 media. The lumen of each horn was rinsed with M2 media (M7167, 108 
Sigma, Dorset, UK), using a 1ml syringe with a 30G needle. The blastocysts were 109 
collected under a stereoscopic microscope using a glass micropipette and rinsed twice in 110 
M2 media. Finally they were rinsed once in pre-warmed K+ modified simplex optimized 111 
medium (KSOM, KSOMaa Evolve, ZEKS-050, Zenith Biotech) for at least 30 min until 112 
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embryo transfer. The blastocysts were rinsed in warmed up M2 media and placed in a 113 
transfer pipette.  114 
 115 
Foster mice preparation 116 
The foster CD1 mice were obtained from Harlan Laboratories. The females bedding was 117 
replaced with male bedding to initiate the estrous cycle. At the start of the estrus phase of 118 
the cycle (two days later), the females were mated with vasectomized males to induce the 119 
pseudo-pregnancy state and prepare the reproductive tract to receive the embryos. The 120 
foster pseudo-pregnant mice were selected by the presence of a vaginal plug. On day 3.5 121 
post-mating, females were anesthetized by inhalation of Isofluorane and kept on a warm 122 
plate during the surgery. The left uterine horn was exposed and the top of the utero-tubal 123 
junction was carefully pierced with the tip of a 30G needle where a transfer pipette 124 
loaded with the blastocysts was inserted. The pipette reached the uterine horn (UH) 125 
through the opened utero-tubal junction and delivered the blastocysts. The foster mice 126 
were kept in separate cages with tags, identifying the date of embryo transfer, number of 127 
embryos transferred and treatment. Food and water were supplied ad libitum. 128 
 129 
Histological evaluation of the murine UHs 130 
Sample collection and storage 131 
The foster mice were euthanized by cervical dislocation. UHs were dissected and placed 132 
in petri dishes. The UHs were stored in 10% paraformaldehyde and dehydrated in a series 133 
of ethanol dilutions (70, 90 and 100%) for fixation. Finally UHs were sectioned in two 134 
and embedded in paraffin. The paraffin blocks were cut in transversal sections of 4 ȝP135 
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using a microtome and fixed to normal microscope slides. The sections on the slides were 136 
then stained using the conventional Haematoxylin & Eosin (H&E) method. Briefly, wax 137 
was removed by rinsing twice in xylene for 5 min. Tissue was hydrated in series of 138 
ethanol dilutions (Twice in 99, 95 and 70%) and tap water for 5 min. The slides were 139 
stained with Gill II Haematoxylin (VWR, Lutterworth, UK) for 1 min and rinsed with tap 140 
water for 3 min. The slides were stained in 1% aqueous Eosin (VWR) with 1% Calcium 141 
Carbonate (Sigma) for 5 min and rinsed in tap water for 30 sec. The sections were 142 
dehydrated in serial dilutions of ethanol (70 and 95% for 10 sec and twice 99% for 30 143 
sec) and twice in Xylene (1 and 3 min). Finally the coverslip was fixed with DPX 144 
mountant (VWR).  145 
The cross sections in the slides were imaged using light microscopy (Olympus CKX41; 146 
Southend-on-sea, UK) and captured with the NIS elements software (Version F3.0 SP4; 147 
Nikon, Surrey, UK). The changes of the development of the uterine decidua due to estrus 148 
cycle were observed. 149 
 150 
Morphometric analysis of the UH 151 
The images of 10 cross-sections were captured using the 20x objective and measured 152 
using the software ImageJ (NIH, Bethesda, MD, USA). This step was taken to ensure the 153 
consistency of the measurements along the length of the horn. The scale for ImageJ area 154 
measurements was set using the scale bar (500 µm) given by the capture software. Each 155 
respective area was measured by outlining it with the free hand selection tool and the area 156 
obtained using the measure option. For each UH cross-section the total area (AT; 157 
myometrium, endometrial stroma and epithelium and lumen), endometrial area (Ael; 158 
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including lumen), luminal area (AL) was measured and the number of glands (nG) was 159 
counted. The endometrial area (AE) and the myometral area (AM) were calculated as 160 
follows:  161 
AE  = Ael  - AL 162 
AM  = AT  - Ael 163 
Then the myometral index (Mi), endometrial index (Ei), luminal index (Li) and gland 164 
index (Gi) were calculated as follows: 165 
Mi  = 
AM
AT
 166 
Ei  = 
A
E
AT
 167 
Li  = 
A
L
AT
  168 
Gi  = nG ´  Ei  169 
 170 
Cytokine measurement 171 
Sample collection and storage 172 
The foster mice were euthanized by cervical dislocation. UHs were dissected and placed 173 
LQSHWULGLVKHV7KH8+VZHUHULQVHGZLWKȝO of M2 media using a 1 ml syringe. The 174 
media was collected in 0.5 ml centrifuge tubes and stored at -80°C. 175 
 176 
Cytokine Arrays 177 
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The flushed media samples were analyzed using the Mouse Cytokine Array Panel A kit 178 
(R&D Systems, Abingdon, UK) for the production of 40 soluble proteins: B-Cell Chemo-179 
attractant (BCL), Complement component 5a (C5a), Granulocyte Colony Stimulating 180 
Factor (G-CSF), Granulocyte ± Macrophage Colony Stimulating Factor (GM-CSF), T-181 
Cell Activation-3 (TCA-3), Eotaxin, Soluble Intercellular Adhesion Molecule-1 (sICAM-182 
1), Interferon (IFN)-Ȗ,/-Į,/-ȕ,/-1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-10, IL-183 
13, IL-12 p70, IL-16, IL-17, IL-23, IL-27, Inflammatory Protein (IP)-10, Interferon-184 
inducible T-cell Alpha Chemo-attractant (I-TAC), Keratinocyte Chemo-attractant (KC), 185 
Macrophage Colony-stimulating Factor (M-CSF), MCP-1, MCP-5, Monokine Induced by 186 
Gamma-interferon (MIG), Macrophage Inflammatory Protein (MIP)-Į MIP-ȕ0,3-2, 187 
Regulated upon Activation Normal T-cell Expressed and presumably Secreted 188 
(RANTES), Stromal cell Derived Factor (SDF)-1, Thymus and Activation Regulated 189 
Chemokine (TARC), Tissue Inhibitor of Metalloproteinases (TIMP)-1, Tumor Necrosis 190 
Factor (TNF)-Į DQG 7ULJJHULQJ 5HFHSWRU ([SUHVVHG RQ 0yeloid cells (TREM)-1. The 191 
samples were incubated overnight with the membranes and the detection antibodies at 192 
8°C on a rocking platform. The membranes were rinsed with wash buffer twice for 10 193 
min and incubated with 2 ml of Streptavidin-HRP for 30 min. The membranes were 194 
rinsed twice in wash buffer and 0.5 mL of chemiluminescent reagent was used to develop 195 
the array. Images of the membranes were captured in an image analyzer after 5 min 196 
exposure.  197 
 198 
Cytokines and chemokine quantification 199 
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The chemokine MCP-1 and cytokine IL-ȕ ZHUH HYDOXDWed in the UH flushing 200 
samples by flow cytometry using a Cytokine Bead Array (CBA, BD Biosciences, Oxford, 201 
UK%ULHIO\ȝORIWKHIOXVKHGPHGLDVDPSOHVZHUHLQFXEDWHGZLWKȝORIGLIIHUHQW202 
F\WRNLQH GHWHFWLRQ EHDGV PL[  ȝO RI WKH 3K\FRHU\WKULQ (PE) detection reagent and 203 
LQFXEDWHGIRUK7KHVDPSOHVZHUHZDVKHGZLWKȝORIWKHSURYLGHGZDVKEXIIHUDQG204 
centrifuged at 200 x g for 5 min. The pellets were re-VXVSHQGHGLQȝORIZDVKEXIIHU205 
and analyzed in a FACSArray cytometer (BD Biosciences). The cytokine IL-1RA was 206 
measured using an ELISA kit (PeproTech; London, UK). Briefly 100 ȝO of the flushed 207 
media samples were incubated at room temperature in the anti-IL-1RA antibody pre-208 
coated 96 well plate for 2h. The plate was rinsed 4 times with washing buffer and 100 ȝO 209 
of the secondary biotinylated antibody (500 ng/ml) were added and co-incubated for 2 h. 210 
The plate was rinsed 4 times with the washing buffer and 100 ȝO of the avidin peroxidase 211 
(1:200) were added and incubated for 30 min. Finally the plate was rinsed 4 times with 212 
washing buffer and 100 ȝO of the ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-213 
sulphonic acid)) liquid substrate were added. The optical density was measured in a plate 214 
reader at 405 nm with wavelength correction set at 650 nm.   215 
 216 
In vitro adhesion assay of trophoblast spheroids to the endometrial cells 217 
 218 
Epithelial cell lines culture 219 
RL95-2 cells were cultured in T75 flasks at 37°C in Dulbecco Modified Eagle Medium 220 
(DMEM)/F-12 (Sigma) supplemented with 1% Penicillin/Streptomycin (P/S; Sigma), 5 221 
ȝJPOInsulin (human recombinant insulin; Gibco Invitrogen, Denmark; cat. No. 12585-222 
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014), 1% L-Glutamine (Sigma) and 10% Fetal Bovine Serum (FBS; Sigma) at 37ºC in 223 
5% CO2 atmosphere until reaching confluency.  224 
MCF7 cells grown in DMEM/F-12, supplemented with 10% FBS, 1% P/S, 1% L-225 
Glutamine and 160 ng/ml Insulin in a T75 flask at 37ºC in 5% CO2 atmosphere. At 226 
confluency, cells were washed with Dulbecco Phosphate-Buffered Saline (DPBS; 227 
Sigma), harvested using Trypsin-EDTA (Sigma) and pelleted by centrifugation at 300 x g 228 
for 4 min. Approximately 5x105 RL95-2 cells and 2.5x105 MCF7 cells were transferred 229 
to each well of a 12-well plate and incubated at 37°C for 3-4 days. 230 
 231 
Formation of JAr cells spheroids  232 
JAr cells were grown in RPMI 1640 (Sigma), supplemented with 10% FBS, 1% P/S and 233 
1% L-Glutamine in a T75 flask at 37ºC in 5% CO2 atmosphere. At confluency, cells were 234 
washed with DPBS (Sigma), harvested using Trypsin-EDTA (Sigma) and pelleted by 235 
centrifugation at 300 x g for 4 min. To mimic the blastocyst, multicellular spheroids were 236 
formed from the JAr cells. One million JAr cells were counted with a haemocytometer 237 
and transferred to 5 ml of supplemented RPMI media in 60 x 15 mm Petri dishes. The 238 
spheroids were formed when the cell suspension was spun overnight on a gyratory shaker 239 
(JKA, MTS 2/4 digital, Staufen, Germany) at 280 rpm in a humid atmosphere and 5% 240 
CO2 at 37°C. Approximately 2000 spheroids were obtained per petri dish (approximately 241 
150-ȝPGLDPHWHU. 242 
 243 
Adhesion of JAr spheroids to endometrial cells 244 
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Fifty JAr spheroids were picked and gently delivered to each well of a 12-well plate with 245 
a confluent monolayer of the epithelial cells. They were co-cultured in supplemented 246 
DMEM-F12 at 37°C and 5% CO2. After co-incubation, the initial number of JAr 247 
spheroids was confirmed by visual examination under a stereoscopic microscope. To 248 
remove non-adherent JAr spheroids from the epithelial cell monolayers, the 12-well 249 
culture plate was washed using a horizontal shaking device (Labman Automation LTD, 250 
Stokesley, UK). The plate was incubated for 4 min at 200 rpm and the media was 251 
discarded. Each well was filled with 1 ml of PBS containing Ca2+ and Mg2+ (PBS/Ca-Mg; 252 
Gibco Invitrogen; UK) and then set to shake for 4 min at 200 rpm. Finally, the PBS/Ca-253 
Mg was discarded. The final number of spheroids was counted under the microscope and 254 
the results expressed as the percentage of spheroids from the initial number of spheroids 255 
counted before washing. 256 
 257 
Viability assessment of the epithelial cells 258 
The RL95-2 and MCF7 cells were grown in 12-well plates until total confluence. The 259 
media was replaced with serum free media before they were either activated or not with 260 
PGN and FSL-1 (Invivogen, Toulouse, France). The cells were harvested with 50 µl of 261 
trypsin EDTA to detach them from the wells, collected in 500 µl of media and pelleted by 262 
centrifuging at 300 g for 5 min. The cells were then resuspended in 200 µl of PBS and 263 
divided in two 5 ml cytometry tubes. One sample was used as autofluorescence and the 264 
other used stained with propidium iodide (PI; Life technologies, Paisley, UK) 3 µM and 265 
captured immediately. The samples were read in a FACSCalibur cytometer (BD) 266 
capturing 1x104 events and the percentage of PI positive events (death cells) was 267 
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registered. The results are expressed as percentage of live cells and were compared using 268 
a one-way ANOVA and p < 0.05 was considered significant.  269 
 270 
Experimental Design 271 
 272 
Evaluation of the murine UH after TLR 2/6 activation  273 
Morphological and morphometrical assessment and evaluation of the UH protein 274 
secretion after TLR 2/6 activation 275 
 276 
The foster Swiss mice were mated with vasectomized males to induce the pseudo-277 
pregnancy state. On day 3.5 post-mating, the utero-tubal junction of the left UH was 278 
pierced with the tip of a 30G needle and a transfer pipette was inserted through the 279 
opening to deliver ȝORI)6/-1 (0.ȝJȝO; n = 16) or saline solution as a control group 280 
(n = 10). Mice were sacrificed 4h later (pre-implantation day) or on day 4.5 (implantation 281 
day) and the uterine horns collected. The inflammatory reaction in the UH was assessed 282 
by morphological and morphometric evaluation of the H&E stained samples. The flushed 283 
media samples from the UHs were pooled in four different groups: Ctrl 4h, FSL-1 4h, 284 
Ctrl 24h and FSL-1 24h. The protein production was assessed using the semi-quantitative 285 
Mouse Cytokine Array Panel A kit (R&D Systems) for the presence of 40 different 286 
cytokines. The profile of protein production was compared between the experimental 287 
groups. Furthermore, the concentrations of the cytokines IL-ȕ DQG 0&3-1 were 288 
assessed in each individual sample by CBAs (BD) and IL-1RA with an ELISA kit 289 
(PeproTech) and data were log transformed to normalize distribution. 290 
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 291 
Evaluation of the effect of TLR 2/6 activation on embryo implantation 292 
The Swiss foster mice were prepared for embryo transfer as mentioned above. The utero-293 
tubal junction of the left UH in each mice was pierced with a 30G needle to make an 294 
opening and using a transfer pipette infused with a drop of ȝORIVDOLQHVROXWLRQQ 295 
or FSL-1 ( ȝJȝO; n=16) followed by a gap of air and a drop containing the 12 296 
blastocysts. After 15 days the foster mice were euthanized by cervical dislocation. The 297 
uterine horns were dissected and the number of embryos implanted and fetuses resorbed 298 
was registered (Fig. 1). 299 
 300 
Effect of the activation of epithelial TLR 2 and TLR 2/6 on the adhesion of 301 
trophoblast spheroids. 302 
Adhesion of trophoblast spheroids to epithelial cells treated with different 303 
concentrations of TLR 2 and 2/6 ligands 304 
To determine whether TLR 2 and TLR 2/6 activation is affecting the trophoblast adhesion 305 
to the epithelial cells, we evaluated the effect of different concentrations of Peptidoglycan 306 
(PGN) and FSL-1 on the epithelial cells. The RL95-2 and MCF7 cells were grown in 12-307 
well plates until total confluence. The media was replaced with serum free media before 308 
they were either activated or not with PGN and FSL-1 (Invivogen, Toulouse, France). 309 
The epithelial cells were then stimulated with different concentrations of PGN (0, 5, 10 310 
DQGȝJPORU)6/-1 (10, 100 and 200 ng/ml) for 24 h. JAr spheroids were delivered 311 
onto the confluent monolayers and co-incubated for 1h. Adhesion was assessed as 312 
described. 313 
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 314 
Adhesion of trophoblast spheroids to stimulated epithelial cells at different time 315 
intervals 316 
To understand if co-incubation duration is affecting the outcome of trophoblast binding to 317 
the epithelial cells, the cells were pre-iQFXEDWHGZLWKȝJPORI3*1RU 100 ng/ml of 318 
FSL-1 for 24h. There after 50 JAr spheroids were delivered onto the confluent epithelial 319 
cell monolayers in 12-well plates and co-incubated for 0.5, 1, 2 or 4 h. The adhesion was 320 
assessed as described before. 321 
 322 
Effect of the inhibition of epithelial TLR activation on trophoblast spheroid adhesion 323 
To understand the effect of TLR 2 inhibition in endometrial cells on trophoblast 324 
spheroids binding to endometrial cells, the epithelial cells were either pre-treated or not 325 
with a monoclonal antibody against TLR   ȝJPO QHXWUDOL]LQJ ,J$ PRQRFORQDO326 
Invivogen) or anti-TLR 6 monoclonal antibody (mouse IgG1, 10 ng/ml, Invivogen) 1 h 327 
before the addition of PGN (5 ȝJPORU)6/-1 (10 ng/ml) respectively. After 24 h, 50 328 
JAr spheroids were delivered onto the monolayer and co-incubated for 30 min. Non-329 
adherent spheroids were removed and the percentage of adhered spheroids was 330 
determined. 331 
 332 
The effect of TLR activation on the viability of the epithelial cells 333 
To determine whether TLR 2 and TLR 2/6 activation is affecting the viability of the 334 
epithelial cells; we treated the cells with different concentrations of PGN and FSL-1. The 335 
epithelial cells were then stimulated with different concentrations of PGN (0, 5, 10 and 336 
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 ȝJPO RU )6/-1 (10, 100 and 200 ng/ml) for 24 h. The viability of the cells was 337 
verified by PI staining in the FACS Calibur cytometer.  338 
 339 
Statistical analysis  340 
The results were expressed as mean ± SEM. Statistical analysis was performed using 341 
Statistica (V7; Statsoft UK, Letchworth, UK). The comparison of two experimental 342 
groups was performed with the non-parametric Mann-Whitney U test. The concentration 343 
of the cytokines measured by CBA and ELISA were log transformed to normalize 344 
distribution. Multiple groups were compared with a one-way ANOVA and a Bonferroni 345 
multiple comparison post-test. The effects of FSL-1 and PGN treatments on the co-346 
incubation kinetics were compared with a two-way ANOVA test and a Bonferroni post-347 
test to compare effects between non-stimulated control and treated cells. P  0.05 was 348 
considered to be significant. 349 
 350 
Results: 351 
 352 
Local FSL-1 administration in uterus induced morphological changes in UH.  353 
The saline treated UHs on the pre-implantation day (4h post-treatment) retained the 354 
morphology of a normal UH. The myometrium was dense and endometrial stroma filled 355 
with secretory glands. The endometrial lumen was pseudo-stratified and convoluted, 356 
showing a small luminal space. Finally, an abundant secretory activity in the endometrial 357 
luminal cells and glands could be observed (Fig 2A). In contrast to this, the FSL-1 treated 358 
UH presented an atrophic morphology. The thickness of the myometrium and stroma was 359 
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reduced as well as the number of glands observed. The FSL-1 treated epithelial 360 
endometrial cells morphology changed from columnar pseudo-stratified to simple 361 
columnar/cuboidal shape. Nevertheless, some secretory activity could still be observed 362 
(Fig 2A). The Mi, Ei and Gi were significantly higher in the saline group compared to the 363 
FSL-1 treated group (Fig. 2B). In contrast, the lumen was smaller and more convoluted in 364 
the saline than in the FSL-1 treated (Fig. 2B). In controls, the morphology of the UHs on 365 
the implantation day (24h post-treatment) was similar to the ones at estrus. In addition to 366 
this, the stroma was loose and filled with edema, a characteristic of a decidualized 367 
endometrium. The presence of vacuoles in the cytoplasm of luminal and glandular 368 
epithelial cells confirmed a high secretory activity at this stage. The 24 h FSL-1 treatment 369 
induced an atrophia of the UHs decidua (Fig. 2C). This could be observed in the 370 
reduction of the Mi and Ei of the FSL-1 treated UHs compared to the saline treated UHs 371 
(Fig. 2D). 372 
 373 
FSL-1 treatment of the UHs increased the production of pro-inflammatory cytokines.  374 
Sixteen proteins were detected 4h after treatments and 17 proteins were detected 24h after 375 
treatments in the cytokine array. The FSL-1 treatment of the UH on the pre-implantation 376 
day, increased the production of TNF-Į7,03-1, MCP-1, M-CSF, KC, IL-16, IL-1ra, IL-377 
ȕDQG,)1-Ȗ)LJ3A). From these proteins, the highest difference between FSL-1 and 378 
saline treatments was observed in MCP-1, IL-1ra and IL-ȕ)6/-1 treatment for 24 hrs 379 
increased significantly the production of MCP-1, IL-17, IL-16, IL-13, IL-7, IL-4, IL-1ra, 380 
IL-ȕ ,/-Į DQG &D )LJ 3B). Based on these analyses, each individual sample was 381 
analyzed again by CBA for the production of IL-ȕ, MCP-1 and by ELISA for IL-1RA. 382 
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The FSL-1 treatment of the tissue for 4h considerably increased the production of IL-ȕ, 383 
MCP-1 however the change in IL-1RA production was minimal (Fig. 3C). The 384 
production of IL-1ȕ and MCP-1 after 24h of FSL-1 treatment was lower and no 385 
difference was observed between the different treatments. In contrast, this treatment 386 
significantly increased IL-1RA production  (Fig. 3D). 387 
 388 
Activation of TLR 2/6 in the murine uterine horn affects embryo implantation. 389 
The activation of TLR 2/6 with FSL-1 severely reduced the number of total implantations 390 
in the UH compared to the saline treated horns (45.00 ± 6.49 vs 16.69 ± 5.01%, p < 0.05; 391 
Fig. 4A). The number of total implantations included the embryos that developed to 392 
fetuses and those that were resorbed (implanted embryos that could not develop; Fig. 4B). 393 
The percentage of developed fetuses decreased after the administration of FSL-1 to the 394 
UH (45.56 ± 6.79 vs 26.04 ± 6.84%, p < 0.05; Fig. 4C). On the other hand, we observed 395 
an increase in the percentage of resorbed fetuses in the FSL-1 treated group compared to 396 
the saline group (4.44 ± 1.79 vs 14.17 ± 3.45%, p < 0.05; Fig. 4D).  397 
 398 
The activation of epithelial TLR 2 and TLR 2/6 decreased the adhesion of trophoblasts 399 
spheroids in vitro regardless of the co-incubation time.  400 
The trophoblast spheroids adhered to the cells as soon as 30 min after their introduction 401 
to the wells and this adhesion was always higher in the RL95-2 cells (63.4 ± 4.38% and 402 
37.35 ± 3.02% to MCF7 cells). The effect of the treatment of the epithelial cells with 100 403 
ng/ml of FSL-1 for 24 h on the adhesion of the JAr spheroids was significant for RL95-2 404 
(p < 0.05) and MCF7 cells (p < 0.0001) as well as the effect of the co-incubation time (p 405 
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< 0.0001 for RL95-2 and p < 0.0001 for MCF7). The FSL-1 stimulation was consistent 406 
throughout the time as no interaction was observed in both cell lines (p = 0.6473 for 407 
RL95-2 and p = 0.8718 for MCF7 cells; Fig. 1A and B). The JAr spheroid adhesion was 408 
found significantly different between the non-stimualted control and FSL-1 stimulated 409 
MCF7 cells at 30 min (37.35 ± 3.02 vs 26.56 ± 2.59%, p < 0.01) and 4 h (73.01 ± 2.23 vs 410 
62.28 ± 2.053%, p < 0.01). The treatment of the cells with PGN was also consistent 411 
throughout the stimulation time as no interaction was observed (p = 0.5527 for RL95-2 412 
and p = 0.5663 for MCF7). We observed a significant effect of the treatment of the cells 413 
with 10 ȝJPORI3*1 on the adhesion of JAr spheroids adhered in both RL95-2 (p < 414 
0.0001) and MCF7 cells (p < 0.0001). The effect of time on the adhesion of the spheroids 415 
was also found to be significant in both cell lines (p < 0.0001 for both RL95-2 and 416 
MCF7; Fig. 5A and B). The adhesion of the JAr spheroids to the non-treated RL95-2 417 
cells differ significantly from the PGN treated cells at 1 h (73.79 ± 2.85 vs 64.1 ± 3.9, p < 418 
0.05) and 2h of co-incubation (89.05 ± 2.02 vs 76.39 ± 2.54, p < 0.01). The same effect 419 
was observed in the MCF7 cells at 1 h (73.01 ± 2.43 vs 67.95 ± 3.23, p < 0.05) and 2 h of 420 
co-incubation with the JAr spheroids (84.19 ± 3.11 vs 71.34 ± 4.26, p < 0.01). 421 
 422 
Trophoblast spheroid decreased adhesion to the epithelial monolayer proportional to 423 
the TLR ligand concentration.  424 
The 24h stimulation of RL95-2 and MCF7 cells with 100 and 200 ng/ml of FSL-1 (68.11 425 
± 4.83 and 61.07 ± 4.52 % for RL95 and 41.66 ± 2.82 and 40.21 ± 3.36 % for MCF7) 426 
significantly decreased the adhesion of the JAr spheroids to the monolayer compared to 427 
the non-stimulated control (83.46 ± 2.685 %, p = 0.0012 for RL95 and 58.58 ± 2.43 %, p 428 
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< 0.0005 for MCF7) after one hour of co-incubation (Fig 6A and B). A similar effect was 429 
observed with PGN stimulation. The RL95-2 PGN stimulation with 20 µg/ml 430 
significantly decreased JAr spheroid adhesion compared to the non-stimulated control 431 
(57.09 ± 3.83 vs 72.92 ± 3.74 %, p < 0.05; Fig. 6A). In MCF7 5, 10 and 20 µg/ml of PGN 432 
significantly decreased JAr spheroid adhesion (57.05 ± 3, 47.04 ± 1.23 and 50.19 ± 2.86 433 
% respectively) compared to the non-stimulated control (68.25 ± 2.71 %, p < 0.0001; Fig. 434 
6B). 435 
 436 
The pretreatment of the endometrial cells with TLR blocking antibodies could restore 437 
the spheroid adhesion. 438 
Furthermore, we confirmed the specificity of the TLR effect by blocking their activation 439 
with monoclonal antibodies. The pre-treatment with a monoclonal anti-TLR 6 antibody 440 
followed by FSL-1 stimulation, restored the percentage of adhered JAr spheroids to 441 
RL95-2 cells (59.71 ± 1.91%) and MCF7 cells (30.70 ± 4.54%) compared to non-treated 442 
cells (63.26 ± 2.74% and 31.48 ± 4.087% respectively; Fig. 7A and B).  The pre-443 
treatment of the epithelial cells with a monoclonal anti-TLR 2 blocking-antibody before 444 
the PGN stimulation, allowed JAr spheroids to adhere to the monolayer to similar levels 445 
(58.15 ± 4.14% for RL95-2 and 33.15 ± 4.44% for MCF7) to those observed in the non-446 
stimulated control (61.81 ± 2.65% for RL95-2 and 35.01 ± 3.78% for MCF7; Fig. 7A and 447 
B). The treatment with the antibodies did not show an effect on the adhesion of JAr 448 
spheroids to the monolayers (anti TLR 6: 63.35 ± 2.48% for RL95-2 and 33.08 ± 4.28% 449 
for MCF7; anti TLR 2: 61.96 ± 3.25% for RL95-2 and 36.72 ± 2.45% for MCF7) 450 
whereas the stimulation with FSL-1 and PGN decreased significantly the adhesion of the 451 
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JAr spheroids (FSL-1: 45.70 ± 1.91%, p < 0.0001 for RL95-2 and 18.20 ± 3.66%, p < 452 
0.0005 for MCF7; PGN: 45.34 ± 3.51%, p < 0.0001 for RL95-2 and 24.00 ± 2.87%, p < 453 
0.0001 for MCF7). 454 
 455 
The viability of the epithelial cells was unaltered after TLR activation 456 
The stimulation of the RL95-2 and MCF7 cells with both FSL-1 and PGN did not affect 457 
the viability of the cells. Around 90% of the non-stimulated cells remain viable after 458 
harvesting from the wells. The viability of the cells stimulated with FSL-1 or PGN was 459 
also around 90% of the total population (Figure 8). 460 
 461 
Discussion 462 
Embryo implantation is a complex event initiated by the adhesion of the trophectoderm to 463 
the endometrial epithelial cells. This is followed by the trophoblast invasion into the 464 
uterine decidua. Two major factors are involved in a successful implantation, a good 465 
embryo quality and proper endometrial receptivity. Any disturbance in the intricate 466 
crosstalk of hormones, cytokines, and adhesion factors during this critical period of time 467 
could lead to implantation failure[32,33].  468 
 469 
In our study using an in vivo murine model, we explored the characteristics of the UH on 470 
pre-implantation and implantation day. We were able to create an inflammatory 471 
environment in the UH by stimulating the innate immune system via TLR 2/6 ligand and 472 
observe how it could affect the tissue structure and impair embryo implantation. The 473 
inflammatory insult in the UH strongly affected the architecture of the different layers of 474 
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the tissue. This effect could be observed as soon as 4 h of the FSL-1 administration, when 475 
the endometrium is remodeling for suitable embryo receptivity. This might indicate that 476 
the epithelial and stromal cells of the uterus are sensitive to innate immune activation via 477 
TLR stimulation as a protective mechanism for the mother. Stromal cells have been 478 
found necessary to mediate immune responses in different body tissues. They offer a 479 
substrate for the migrating leukocytes and orchestrate part of the adaptive immune 480 
responses[34]. During embryo implantation, the uterine stromal cells provide a scaffold 481 
for migrating cytotrophoblasts and establishment of the spiral arteries. The stromal 482 
sensitivity to respond to inflammatory stimuli has been studied, where administration of 483 
i.p. Poly I:C (TLR 3 ligand) to mice affects stromal decidualization and vascularization of 484 
the uterus[35]. In our experiments the innate immune activation was performed via FSL-1 485 
which is a synthetic diacyl lipopeptide specific ligand for TLR 2/6[36]. It is possible that 486 
the effect on the tissue remodeling will occur regardless of the type of TLR activated. In 487 
fact, the capacity of the endometrial cells to react to foreign entities has been assessed 488 
previously where the exposure of the UH to the toxic compound di-(2-ethylhexyl)-489 
phtalate (DEHP) is able to affect tissue decidualization and impair embryo 490 
implantation[37]. The current methods to evaluate the estrogenic effects of toxic 491 
compounds on the UH is based on the uterotrophic assay developed in the 1930s. It 492 
estimate the weight of the horns after treatment and gives a description of the 493 
morphological characteristics of the uterine layers and cells[38]. In humans, the criteria to 494 
date the endometrium based on pathologist observations were established by Noyes in the 495 
1950s. It estimates scores for the different morphological changes of the endometrial 496 
characteristics in gland, epithelia and stromal development due to the phase of the 497 
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cycle[39]. In our morphometry assessment, we were able to measure accurately the areas 498 
of the different UH compartments with the help of the digital imaging tools. Also the 499 
possible differences due to the horn size and sampling along the length of the horn were 500 
normalized with the calculation of the indexes. This technique can potentially be used as 501 
an effective method of estimating toxic effects of chemical compounds on the uterine 502 
horn of different mammalian species, although more standardization in its validity is 503 
required.  504 
 505 
The implantation as mentioned before is an agreement between the maternal tract 506 
and the embryo. Cytokines produced by the maternal tract are fundamental effectors, 507 
which also peculiarly resemble an inflammatory reaction. By profiling the UH secretions, 508 
we were able to observe a disruption in the cytokine levels when the uterine TLR 2/6 was 509 
activated. After 4 h of stimulation (pre-implantation day) three proteins were up-510 
regulated: MCP-1 (CCL2), IL-ȕDQG,/-1ra. The three of them share important roles in 511 
both embryo implantation and in inflammation. The stimulation of the endometrium 512 
epithelia with IL-ȕ has been found induce the expression of endometrial adhesion 513 
molecules necessary for embryo apposition and adhesion[40]. MCP-1 has been proven to 514 
be inducible by in vitro stimulation of TLR 2/6 in murine uterine epithelial cells and 515 
TLR4 in uterine epithelial and stromal cells[41]. The increase in IL-1RA production after 516 
24 h of TLR 2/6 stimulation could interfere with the embryo ± mother crosstalk 517 
antagonizing IL-1ȕ. The i.p. administration of IL-1RA to mice in the pre-implantation 518 
period reduces drastically embryo implantation[42]. After 24 h of FSL-1 treatment we 519 
observed a distinctive change in pattern of expression of cytokines towards a response 520 
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type Th17. The Th17 response can lead to autoimmune diseases, chronic inflammatory 521 
disorders and infectious diseases[43]. In the endometrium they have been associated with 522 
cases of unexplained infertility[44,45] and in  response to C. muridarum, the murine 523 
homologue of C. trachomatis[46]. This pathogen can initially be recognized by TLR 2 524 
prior to an adaptive response[16].  525 
 526 
The reduction of embryo implantation confirmed a direct effect of the activation 527 
of uterine TLR 2/6 on embryo implantation. This activation was able to affect the 528 
development of the uterine tissue and the secreted protein profile necessary for 529 
implantation. As observed, the lack of a receptive epithelium to adhere would affect the 530 
apposition and adhesion of the blastocyst. It might be possible that the molecular 531 
characteristics of the endometrial cells could be also affected by this stimulation. It is 532 
unlikely that the treatment of the UH with the TLR 6 agonist could harm the embryos and 533 
could be the reason of embryo implantation loss. A previous report has demonstrated that 534 
the first trimester trophoblast lack the expression of TLR 6 and stimulation does not 535 
change blastocyst viability[47]. The FRT has been proved to be sensitive to TLR 536 
stimulation in vivo, for example the infusion of LPS to the murine UH induces a TLR 4 537 
dependent inflammatory pelvic disease [48]. It has also been observed that the 538 
administration of i.p. LPS to mated mice on day 5.5 could increase fetal loss[49]. The 539 
atrophic stroma observed after TLR 2/6 stimulation, would offer a deficient soil for the 540 
embryo to invade and start its development. This is likely to be a contributing factor for 541 
the increase in embryo resorption observed in our investigation. Similar to this study, it 542 
has been observed that administration of i.p. Poly I:C, TLR 3 ligand can decrease the 543 
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implantation rate and increase the percentage of resorbed embryos by impairing stromal 544 
decidualization and spiral arteries development[35]. Hence, a potential reason for the low 545 
success rate of implantation after embryo transfer is the simple manipulation of the 546 
uterine horn or endometrium during embryo transfer procedures in human or livestock 547 
that could damage the tissue. This damage could induce a sterile inflammatory process by 548 
the release of danger associated molecular patterns (DAMPs) molecules that are also 549 
recognized by the TLRs, initiating an inflammatory process and leading to embryo 550 
implantation failure. A potential way of clarifying these effects on the murine UH and a 551 
future scope of our research is to use a TLR6 KO mouse. In this way we would be able to 552 
test the effects of TLR activation on both tissue structure and embryo implantation. 553 
 554 
To corroborate our observations in the murine model of embryo implantation, we used an 555 
in vitro human trophoblast spheroid adhesion model as mentioned before. The percentage 556 
of spheroids adhered increased proportionally with time, as observed previously[50,51]. 557 
The JAr cells have been described as a very invasive choriocarcinoma cell line[50]. The 558 
interaction of MCF7 cells with first trimester placental explants has been observed 559 
before. The trophoblast explants affected MCF7 proliferation and induced apoptosis in 560 
long co-incubation times. [52]. Our experiments were carried out in short co-incubation 561 
times where we were able to observe adhesion of trophoblast to both epithelial cells.  562 
Nevertheless a better interaction was observed with the endometrial cells as trophoblast 563 
cells adhered them in a higher percentage and faster than the MCF7 cells. 564 
 565 
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Stimulation of TLR 2 and 2/6 in the epithelial cells decreased the percentage of attached 566 
spheroids to the monolayers. It is unclear how the TLR activation can influence 567 
endometrial receptivity. The fact that we observed a decrease in trophoblast spheroid 568 
adhesion in both epithelial cell lines after TLRs activation might suggest that the TLR 569 
activation effect relies on modification of cellular adhesion capability. Expression of 570 
surface adhesion molecules, cell polarity or even cytoskeletal arrangement necessary for 571 
the cell-cell interactions might be involved. In our study it was clear that the decrease in 572 
trophoblast adhesion to epithelial cells came from the TLR activation on the epithelial 573 
cells. The inhibition of TLR 6 and TLR 2 with specific antibodies restored the ability of 574 
the JAr spheroids to bind to both FSL-1 and PGN stimulated RL95-2 cells. It is important 575 
to consider that TLR 2 is a particular receptor of the TLR family. It can form homodimers 576 
and heterodimers with either TLR 1 or TLR 6 increasing the range of ligands that TLR 2 577 
can recognize, from bacterial PGN to diacyl and triacyl lipopeptides[53,54]. TLR 2/6 578 
functionality is dependent on the dimerization and the recognition of the ligand by both 579 
TLRs. If one of them is absent, then the activation by the diacylated lipopeptides will not 580 
occur[19,55]. A previous report from our laboratory explored how the stimulation of TLR 581 
5 with Flagellin can induce a similar effect on the adhesion of trophoblast cells to 582 
endometrial epithelial cells[24]. Finally, as shown in our results (Figure 8), the decrease 583 
in spheroid adhesion to the endometrial cells cannot be attributed to the effect of the TLR 584 
stimulation on the viability of the cells. Together these results suggest that the activation 585 
of TLRs will have a detrimental effect on implantation and this might happen regardless 586 
of which TLR molecule is being stimulated. 587 
 588 
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Clinically, endometrial TLR 2 might be playing a very important role in the 589 
recognition of pathogens that cause Sexually Transmitted Diseases (STDs) and infertility. 590 
The most common bacterial transmitted STD caused by the intracellular obligated gram-591 
negative pathogen C. trachomatis. Chlamydia can cause a cervical infection that if 592 
ascends into the upper tract can generate Pelvic Inflammatory Disease (PID) and 593 
infertility[56]. Chlamydia can be recognized by TLR 2 in the intracellular inclusions and 594 
induce the production of IL-8[16]. Furthermore this recognition and the initiation of the 595 
immune responses is dependent on TLR 2 and not TLR 4 and mice lacking TLR 2 596 
showed a reduced oviductal inflammation[57].  597 
 598 
Determining the suitable endometrial conditions for the implantation of the 599 
embryo is a topic under constant research[2,3,5,6,33]. The correct diagnose of infertility 600 
can increase significantly the success of pregnancy for women with fertility problems and 601 
couples undergoing IVF treatment. With further research on the mechanisms responsible 602 
for the effects observed here, it would become possible to design and direct a therapy 603 
targeting the endometrial innate immune system to increase the implantation success. Our 604 
data support the importance of TLRs during the time of implantation suggesting that they 605 
could be used as a potential target in management of infertility cases. 606 
 607 
Acknowledgments 608 
 609 
We would like to thank the personal in charge of the mice facilities of INIA in Madrid for 610 
their support. We acknowledge CONACyT in Mexico for providing a scholarship and the 611 
 31 
COST Action FA0702 (GEMINI) for granting a Short Term Scientific Mission for Javier 612 
Arturo Sánchez-López.  613 
 614 
References 
 
1. Dekel N, Gnainsky Y, Granot I, Mor G: Inflammation and implantation. Am J 
Reprod Immunol 2010 Jan.;63:17±21.  
2. Lessey BA: Endometrial receptivity and the window of implantation. Baillieres 
Best Pract Res Clin Obstet Gynaecol 2000 Oct.;14:775±788.  
3. Dimitriadis E, Nie G, Hannan NJ, Paiva P, Salamonsen LA: Local regulation of 
implantation at the human fetal-maternal interface. Int J Dev Biol 2010;54:313±
322.  
4. Singh H, Aplin JD: Adhesion molecules in endometrial epithelium: tissue integrity 
and embryo implantation. J Anat 2009 Jul.;215:3±13.  
5. Paria BC, Lim H, Das SK, Reese J, Dey SK: Molecular signaling in uterine 
receptivity for implantation. Semin Cell Dev Biol 2000 Apr.;11:67±76.  
6. McEwan M, Lins RJ, Munro SK, Vincent ZL, Ponnampalam AP, Mitchell MD: 
Cytokine regulation during the formation of the fetal-maternal interface: focus on 
cell-cell adhesion and remodelling of the extra-cellular matrix. Cytokine Growth 
Factor Rev 2009 Jun.;20:241±249.  
7. Walker CG, Meier S, Littlejohn MD, Lehnert K, Roche JR, Mitchell MD: 
Modulation of the maternal immune system by the pre-implantation embryo. BMC 
Genomics 2010;11:474.  
8. Pellati D, Mylonakis I, Bertoloni G, Fiore C, Andrisani A, Ambrosini G, et al.: 
Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol 2008 
Sep.;140:3±11.  
9. Hickey DK, Patel MV, Fahey JV, Wira CR: Innate and adaptive immunity at 
mucosal surfaces of the female reproductive tract: stratification and integration of 
immune protection against the transmission of sexually transmitted infections. 
Journal of Reproductive Immunology 2011 Mar. 1;88:185±194.  
10. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L: Innate and adaptive immunity 
in female genital tract: cellular responses and interactions. Immunol Rev 2005 
Aug.;206:306±335.  
11. Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: 
update on Toll-like receptors. Nat Immunol 2010 May 1;11:373±384.  
12. Horne AW, Stock SJ, King AE: Innate immunity and disorders of the female 
reproductive tract. Reproduction 2008 Jun. 1;135:739±749.  
 33 
13. Aboussahoud W, Aflatoonian R, Bruce C, Elliott S, Ward J, Newton S, et al.: 
Expression and function of Toll-like receptors in human endometrial epithelial cell 
lines. Journal of Reproductive Immunology 2010 Jan.;84:41±51.  
14. Fazeli A, Bruce C, Anumba DO: Characterization of Toll-like receptors in the 
female reproductive tract in humans. Hum Reprod 2005 May;20:1372±1378.  
15. Koga K, Mor G: Expression and function of toll-like receptors at the maternal-fetal 
interface. Reprod Sci 2008 Apr. 1;15:231±242.  
16. O'Connell CM, Ionova IA, Quayle AJ, Visintin A, Ingalls RR: Localization of 
TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by 
intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol 
Chem 2006 Jan. 20;281:1652±1659.  
17. Gil ML, Gozalbo D: TLR2, but not TLR4, triggers cytokine production by murine 
cells in response to Candida albicans yeasts and hyphae. Microbes Infect 2006 Jul. 
1;8:2299±2304.  
18. Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, Lucas JJ, et al.: 
Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of 
cytokines by human female reproductive tract epithelial cells. Infection and 
Immunity 2006 Oct.;74:5773±5779.  
19. Buwitt-Beckmann U, Heine H, Wiesmüller K-H, Jung G, Brock R, Akira S, et al.: 
Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J 
Immunol 2005 Jan.;35:282±289.  
20. Okusawa T, Fujita M, Nakamura J-I, Into T, Yasuda M, Yoshimura A, et al.: 
Relationship between structures and biological activities of mycoplasmal 
diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. 
Infection and Immunity 2004 Mar.;72:1657±1665.  
21. Brown J, Wang H, Hajishengallis GN, Martin M: TLR-signaling networks: an 
integration of adaptor molecules, kinases, and cross-talk. Journal of Dental 
Research 2011 Mar. 31;90:417±427.  
22. Aflatoonian R, Tuckerman E, Elliott SL, Bruce C, Aflatoonian A, Li TC, et al.: 
Menstrual cycle-dependent changes of Toll-like receptors in endometrium. Hum 
Reprod 2007 Feb.;22:586±593.  
23. Koga K, Mor G: Toll-like receptors at the maternal-fetal interface in normal 
pregnancy and pregnancy disorders. Am J Reprod Immunol 2010 Mar. 29;63:587±
600.  
24. Aboussahoud W, Bruce C, Elliott S, Fazeli A: Activation of Toll-like receptor 5 
decreases the attachment of human trophoblast cells to endometrial cells in vitro. 
Human Reproduction 2010 Sep.;25:2217±2228.  
 34 
25. Sharkey AM, Smith SK: The endometrium as a cause of implantation failure. Best 
practice & research Clinical obstetrics & gynaecology 2003 Apr. 1;17:289±307.  
26. Wang H, Dey SK: Roadmap to embryo implantation: clues from mouse models. 
Nat Rev Genet 2006 Mar. 1;7:185±199.  
27. Silver LM: Mouse genetics : concepts and applications. New York, Oxford 
University Press, 1995. 
28. Hannan NJ, Paiva P, Dimitriadis E, Salamonsen LA: Models for study of human 
embryo implantation: choice of cell lines? Biol Reprod 2010 Feb.;82:235±245.  
29. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD: Characterization of a 
new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 
1983 Mar.;19:147±158.  
30. Levenson AS, Jordan VC: MCF-7: the first hormone-responsive breast cancer cell 
line. 1997. 
31. Thie M, Röspel R, Dettmann W, Benoit M, Ludwig M, Gaub HE, et al.: 
Interactions between trophoblast and uterine epithelium: monitoring of adhesive 
forces. Hum Reprod 1998 Nov.;13:3211±3219.  
32. Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early 
pregnancy. N Engl J Med 2001 Nov. 8;345:1400±1408.  
33. Singh M, Chaudhry P, Asselin E: Bridging endometrial receptivity and 
implantation: network of hormones, cytokines, and growth factors. The Journal of 
endocrinology 2011 Jul.;210:5±14.  
34. Sato A, Iwasaki A: From The Cover: Induction of antiviral immunity requires 
Toll-like receptor signaling in both stromal and dendritic cell compartments; in : 
Proceedings of the National Academy of Science. 2004, pp 16274±16279. 
35. Zhang J, Wei H, Wu D, Tian Z: Toll-like receptor 3 agonist induces impairment of 
uterine vascular remodeling and fetal losses in CBA x DBA/2 mice. Journal of 
Reproductive Immunology 2007 Jun.;74:61±67.  
36. Shibata K, Hasebe A, Into T, Yamada M, Watanabe T: The N-terminal lipopeptide 
of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is 
responsible for the expression of intercellular adhesion molecule-1 on the cell 
surface of normal human gingival fibroblasts. J Immunol 2000 Dec. 1;165:6538±
6544.  
37. Li R, Yu C, Gao R, Liu X, Lu J, Zhao L, et al.: Effects of DEHP on endometrial 
receptivity and embryo implantation in pregnant mice. J Hazard Mater 2012 Nov. 
30;241-242:231±240.  
 35 
38. OECD: OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects 
Test No. 440: Uterotrophic Bioassay in Rodents A short-term screening test for 
oestrogenic properties. OECD Publishing, 2007. 
39. Fadare O, Zheng W: Histologic dating of the endometrium: accuracy, 
reproducibility, and practical value. Adv Anat Pathol 2005 Mar. 1;12:39±46.  
40. Geisert R, Fazleabas A, Lucy M, Mathew D: Interaction of the conceptus and 
HQGRPHWULXPWRHVWDEOLVKSUHJQDQF\LQPDPPDOVUROHRILQWHUOHXNLQȕ&HOO
Tissue Res 2012 Sep.;349:825±838.  
41. Soboll G, Schaefer TM, Wira CR: Effect of Toll-Like Receptor (TLR) Agonists on 
TLR and Microbicide Expression in Uterine and Vaginal Tissues of the Mouse. 
American Journal of Reproductive Immunology 2006 Jun. 1;55:434±446.  
42. Simón C, Valbuena D, Krüssel J, Bernal A, Murphy CR, Shaw T, et al.: 
Interleukin-1 receptor antagonist prevents embryonic implantation by a direct 
effect on the endometrial epithelium. Fertil Steril 1998 Nov.;70:896±906.  
43. Qu N, Xu M, Mizoguchi I, Furusawa J-I, Kaneko K, Watanabe K, et al.: Pivotal 
Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory 
Diseases. Clinical and Developmental Immunology 2013;2013:1±13.  
44. Nakashima A, Ito M, Shima T, Bac ND, Hidaka T, Saito S: Accumulation of IL-
17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol 
2010 Jul. 1;64:4±11.  
45. Jasper MJM, Tremellen KPK, Robertson SAS: Primary unexplained infertility is 
associated with reduced expression of the T-regulatory cell transcription factor 
Foxp3 in endometrial tissue. Mol Hum Reprod 2006 Apr. 30;12:301±308.  
46. Scurlock AM, Frazer LC, Andrews CW, O'Connell CM, Foote IP, Bailey SL, et 
al.: Interleukin-17 Contributes to Generation of Th1 Immunity and Neutrophil 
Recruitment during Chlamydia muridarum Genital Tract Infection but Is Not 
Required for Macrophage Influx or Normal Resolution of Infection. Infection and 
Immunity 2011 Feb. 17;79:1349±1362.  
47. Abrahams VM, Aldo PB, Murphy SP, Visintin I, Koga K, Wilson G, et al.: TLR6 
modulates first trimester trophoblast responses to peptidoglycan. J Immunol 2008 
Apr. 30;180:6035±6043.  
48. Sheldon IM, Roberts MH: Toll-like receptor 4 mediates the response of epithelial 
and stromal cells to lipopolysaccharide in the endometrium. PLoS ONE 
2010;5:e12906.  
49. Friebe A, Douglas AJ, Solano E, Blois SM, Hagen E, Klapp BF, et al.: 
Neutralization of LPS or blockage of TLR4 signaling prevents stress-triggered 
fetal loss in murine pregnancy. J Mol Med 2011 Jul. 1;89:689±699.  
 36 
50. Hohn HP, Linke M, Denker HW: Adhesion of trophoblast to uterine epithelium as 
related to the state of trophoblast differentiation: in vitro studies using cell lines. 
Mol Reprod Dev 2000 Oct.;57:135±145.  
51. John NJ, Linke M, Denker HW: Quantitation of human choriocarcinoma spheroid 
attachment to uterine epithelial cell monolayers. In Vitro Cell Dev Biol Anim 1993 
Jun.;29A:461±468.  
52. Tartakover-Matalon S, Mizrahi A, Epstein G, Shneifi A, Drucker L, Pomeranz M, 
et al.: Breast cancer characteristics are modified by first trimester human placenta: 
in vitro co-culture study. Human Reproduction 2010 Sep. 15;25:2441±2454.  
53. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D: Cutting 
edge: recognition of Gram-positive bacterial cell wall components by the innate 
immune system occurs via Toll-like receptor 2. J Immunol 1999 Jul. 1;163:1±5.  
54. Buwitt-Beckmann U, Heine H, Wiesmüller K-H, Jung G, Brock R, Akira S, et al.: 
TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 
2006 Apr. 7;281:9049±9057.  
55. Kang JY, Nan X, Jin MS, Youn S-J, Ryu YH, Mah S, et al.: Recognition of 
lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. 
Immunity 2009 Dec. 18;31:873±884.  
56. Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS: Inflammation in 
reproductive disorders. Reprod Sci 2009 Feb.;16:216±229.  
57. Darville TT, O'Neill JMJ, Andrews CWC, Nagarajan UMU, Stahl LL, Ojcius 
DMD: Toll-like receptor-2, but not Toll-like receptor-4, is essential for 
development of oviduct pathology in chlamydial genital tract infection. J Immunol 
2003 Dec. 1;171:6187±6197.  
 
 
 
 
 
 
 
 
 37 
List of figures 
 
Figure 1. Donor and foster mice preparation for embryo transfer and FSL-1 
administration scheme. Scheme of super-ovulation of embryo donor mice, foster mother 
preparation, administration of FSL-1 and blastocyst transfer. 
 
 
Figure 2. Uterine horn morphology and morphometry after TLR 2/6 stimulation. Cross-
section of the H&E stained murine UH treated with saline solution or FSL-1 (0.1 ȝJȝO
after 4h on pre-implantation day day (A) and after 24h on implantation day (C). Images 
were taken at 40x and 400x magnifications. Morphometric analysis of the different layers 
of saline and FSL-1 treated UHs: endometrium (Ei), myometrium (Mi), lumen (Li) and 
glands (Gi) on pre-implantation (B) implantation (D) day. The bars are representative of 
the mean ± SEM from 10 cross-sections of each UH. The statistical comparisons between 
saline control and FSL-1 treatments were performed with a Mann Whitney t-test where * 
SLu: Lumen, En: Endometrium and My: Myometrium.  
 
Figure 3. Production of soluble proteins in the uterine horn lumen stimulated with TLR 
2/6 ligand. Semi quantitative profiling of the luminal lavages after 4 (A) and 24 h (B) of 
saline or FSL-1 treatment ȝJȝO. Quantification of the production of IL-ȕ0&3-1 
and IL-1RA after 4 (C) or 24 h (D) of saline (white bars) or FSL-1 (black bars) treatment. 
The bars on the array represent the mean ± SEM of two technical replicates of the pooled 
flushing samples of saline (n=10) or FSL-1 (n=16) treated UHs. The bar charts of IL-ȕ
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MCP-1 and IL-1RA represent the mean ± SEM of the logarithmic concentration of the 
different samples of the UH flushed media. Statistical differences between treatments 
were analyzed by Mann Whitney t-test (*S 
 
Figure 4. Murine embryo implantation on FSL-1 treated uterine horns. The percentage of 
total embryos implanted was assessed on day 16 on the control (n=15) and FSL-1 
(ȝJȝO n=16) treated foster mothers (A). Representative image of implanted and 
resorbed embryos in the murine UH (B). The percentage of embryos implanted (C) and 
embryos resorbed (D) was estimated and compared between control and FSL-1 treated 
UHs. The bars are the mean ± SEM of the control and FSL-1 treated foster mice. The 
statistical comparisons between treatments were performed using a Mann Whitney t-test 
(*p  0.05). 
 
Figure 5. Kinetics of adhesion of trophoblast spheroids on epithelial cells stimulated with 
FSL-1 and PGN. The percentage of adhesion of JAr spheroids to A) endometrial or B) 
MCF7 cells was determined after a kinetic of adhesion (0.5, 1, 2 and 4h). The adhesion of 
the spheroids to endometrial untreated cells (y) was compared to the endometrial cells 
treated () with FSL-1 100 ng/ml treated or PGN 10 ȝJPO treated. Each point represents 
the mean ± SEM of four independent experiments treatments were compared by a two-
way ANOVA to test interaction between effects, treatment and co-incubation time. 
Furthermore the difference between control and treated groups per individual time points 
was assessed with a Bonferroni multiple comparisons post-test (*p  0.05 was considered 
significant). 
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Figure 6. Effect of the concentration of FSL-1 and PGN on the adhesion of the JAr 
spheroids to the epithelial monolayers. The adhesion of JAr spheroids to the A) 
endometrial or B) MCF7 cells was determined after their pre-treatment with different 
concentrations of FSL-1 (50, 100 and 200 ng/ml) or 3*1DQGȝJPO7KHGDWD
represents the mean of 3 independent experiments ± SEM. A multifactorial ANOVA with 
Bonferroni multiple comparison test was used to compare the stimulated vs. non-
stimulated groups (*p  0.05).  
 
Figure 7. Effects of the inhibition of epithelial TLR 6 and TLR 2 activation on the 
adhesion capacity of the JAr spheroids. The A) RL95-2 or B) MCF7 cells were pre-
treated or not with an IgG anti-TLR6 antibody (10 ng/ml) or IgA monoclonal anti TLR-2 
DQWLERG\  ȝJPO DQG VWLPXODWHG with FSL-1 (10 ng/ml) or 3*1  ȝJPO
respectively. The percentage of adhesion to the non-treated or different treated groups 
was assessed. The data represents the mean of 3 independent experiments ± SEM. A 
multifactorial ANOVA with Bonferroni multiple comparison test was used to compare 
the different groups (*p < 0.05).  
 
Figure 8. Effect of the concentration of FSL-1 and PGN on the viability of the epithelial 
cells. The viability of A) RL95-2 or B) MCF7 cells was determined after their treatment 
with different concentrations of FSL-1 (50, 100 and 200 ng/ml) or PGN (5, 10 and 20 
ȝJPO 7KH GDWD UHSUHVHQWV WKH PHDn of 3 independent experiments ± SEM. A 
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multifactorial ANOVA with Bonferroni multiple comparison test was used to compare 
the stimulated vs. non-VWLPXODWHGJURXSVS 
 
 
 
